PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer
Article in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (May 2024)
The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.
Rapamycin vs TORin-1 or Gleevec vs Nilotinib: Simple chemical evolution that converts PAK1-blockers to TOR-blockers or vice versa?
Article in Drug Discoveries & Therapeutics (April 2024)
Id1, Spp1 and Pak3 are biomarkers of Smad4 and TGF-β1 dependency in conditional intestinal adenoma, organoids and colorectal cancer
Preprint in bioRxiv (March 2024)